Gimeracil

CAS No.

103766-25-2

MDL No.

MFCD00923843

C₅H₄ClNO₂

145.54

InChI Key

ZPLQIPFOCGIIHV-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
5 g	98%	$8	In Stock
10 g	97%	$12	In Stock
25 g	98%	$19	In Stock
100 g	98%	$67	In Stock
500 g	98%	$319	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

5 g

98%

In Stock

10 g

97%

$12

In Stock

25 g

98%

$19

In Stock

100 g

98%

$67

In Stock

500 g

98%

$319

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Gimeracil is an organic molecule.

CAS No.	103766-25-2
Product Name	Gimeracil

Biological Targets

DPYD

Associated Conditions

non-small cell lung carcinoma·Malignant Pancreatic Neoplasm·hepatocellular carcinoma·breast cancer·head and neck malignant neoplasia·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Gimeracil

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function.

Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer.

A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells.

Documentation

Similar Products

4-hydroxy-5-methylpyridin-2(1H)-one